SRC and breast cancer: The regulatory circuit impedes Cx43 expression, leading to an impairment of the interaction of Cx43 with c-Src and subsequently activation of PI3K/Akt pathway, which further retards Cx43 expression, thereby inducing EMT and TAM resistance in breast cancer (Fig. 10G).